These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 1715838

  • 1. Characteristic behavior of serum elastase 1 in pancreatic cancer.
    Kimura T, Ito T, Sumii T, Muranaka T.
    Fukuoka Igaku Zasshi; 1991 Jun; 82(6):355-61. PubMed ID: 1715838
    [Abstract] [Full Text] [Related]

  • 2. [Early detection of pancreatic cancer by serum markers].
    Nakae Y, Naruse S, Shibata T, Kitagawa M, Kondo T, Hayakawa T, Kuno N, Kurimoto K.
    Rinsho Byori; 1994 Feb; 42(2):139-42. PubMed ID: 7511183
    [Abstract] [Full Text] [Related]

  • 3. Serum immunoreactive elastase: is it useful for the diagnosis of pancreatic cancer?
    Gullo L, Pezzilli R, Ventrucci M, Lesi C, Zoni L, D'Ambrosi A, Alvisi V.
    Pancreas; 1989 Feb; 4(3):335-8. PubMed ID: 2734276
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of serum pancreatic enzymes, carbohydrate antigen 19-9, and carcinoembryonic antigen in various pancreatic diseases.
    Satake K, Kanazawa G, Kho I, Chung Y, Umeyama K.
    Am J Gastroenterol; 1985 Aug; 80(8):630-6. PubMed ID: 2411125
    [Abstract] [Full Text] [Related]

  • 5. [Serum pancreatic enzymes in the diagnosis of carcinoma of the pancreas].
    Pezzilli R, Ventrucci M, Talarico R, Naldoni P, Cassano A, Gullo L.
    G Ital Oncol; 1989 Aug; 9(1):7-13. PubMed ID: 2468605
    [Abstract] [Full Text] [Related]

  • 6. Sensitive serum markers for detecting pancreatic cancer.
    Hayakawa T, Kondo T, Shibata T, Hamano H, Kitagawa M, Sakai Y, Ono H.
    Cancer; 1988 May 01; 61(9):1827-31. PubMed ID: 2451556
    [Abstract] [Full Text] [Related]

  • 7. Evaluating the role of serum elastase 1 in the diagnosis of pancreatic cancer.
    Wu D, Qian JM, Deng RX, Jiang WJ, Chen YJ, Liu XH, Lu XH.
    Chin J Dig Dis; 2006 May 01; 7(2):117-20. PubMed ID: 16643340
    [Abstract] [Full Text] [Related]

  • 8. Serum elastase 1 appears specific for cancer of the pancreatic head.
    Ito T, Kimura T, Nawata H.
    Am J Gastroenterol; 1991 Dec 01; 86(12):1778-83. PubMed ID: 1962622
    [Abstract] [Full Text] [Related]

  • 9. [Value of serum CA 19-9 determination in the diagnosis of pancreatic carcinoma].
    Pei DP.
    Zhonghua Wai Ke Za Zhi; 1990 Oct 01; 28(10):625-7, 638-9. PubMed ID: 2086060
    [Abstract] [Full Text] [Related]

  • 10. [Serum pancreatic enzymes and enzyme inhibitor as a tumor marker for pancreatic cancer].
    Ogawa M.
    Rinsho Byori; 1986 Nov 01; 34(11):1229-35. PubMed ID: 2434691
    [No Abstract] [Full Text] [Related]

  • 11. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.
    Ni XG, Bai XF, Mao YL, Shao YF, Wu JX, Shan Y, Wang CF, Wang J, Tian YT, Liu Q, Xu DK, Zhao P.
    Eur J Surg Oncol; 2005 Mar 01; 31(2):164-9. PubMed ID: 15698733
    [Abstract] [Full Text] [Related]

  • 12. [Developing a hospital-based high risk scoring model and screening strategy for pancreatic cancer].
    Deng RX, Lu XH, Wang L, Li H, Qian JM, Yang AM, Zhong SX, Guo XZ, Zhou L, Wu X, Yang XO, Jiang WJ.
    Zhonghua Yi Xue Za Zhi; 2005 Aug 03; 85(29):2038-42. PubMed ID: 16313796
    [Abstract] [Full Text] [Related]

  • 13. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer.
    Ghazale A, Chari ST, Smyrk TC, Levy MJ, Topazian MD, Takahashi N, Clain JE, Pearson RK, Pelaez-Luna M, Petersen BT, Vege SS, Farnell MB.
    Am J Gastroenterol; 2007 Aug 03; 102(8):1646-53. PubMed ID: 17555461
    [Abstract] [Full Text] [Related]

  • 14. Changes in serum levels of pancreatic isoamylase, lipase, trypsin, and elastase 1 after endoscopic retrograde pancreatography.
    Okuno M, Himeno S, Kurokawa M, Shinomura Y, Kuroshima T, Kanayama S, Tsuji K, Higashimoto Y, Tarui S.
    Hepatogastroenterology; 1985 Apr 03; 32(2):87-90. PubMed ID: 3847383
    [Abstract] [Full Text] [Related]

  • 15. Combined detection of serum tumor markers for differential diagnosis of solid lesions located at the pancreatic head.
    Liao Q, Zhao YP, Yang YC, Li LJ, Long X, Han SM.
    Hepatobiliary Pancreat Dis Int; 2007 Dec 03; 6(6):641-5. PubMed ID: 18086633
    [Abstract] [Full Text] [Related]

  • 16. CA 19-9 in serum and pancreatic juice: its role in the differential diagnosis of resectable pancreatic cancer from chronic pancreatitis.
    Malesci A, Evangelista A, Mariani A, Bersani M, Bonato C, Basilico M, Montorsi M, Beretta E.
    Int J Pancreatol; 1988 Dec 03; 3 Suppl 1():S119-23. PubMed ID: 3209865
    [Abstract] [Full Text] [Related]

  • 17. [Pancreatic elastase 1].
    Ogawa M.
    Rinsho Byori; 2001 Nov 03; Suppl 116():131-4. PubMed ID: 11797373
    [Abstract] [Full Text] [Related]

  • 18. [Tumor markers for pancreatic and biliary tract cancer].
    Takezako Y, Okusaka T, Ueno H, Ikeda M, Morizane C, Najima M.
    Gan To Kagaku Ryoho; 2004 Sep 03; 31(9):1443-6. PubMed ID: 15446574
    [Abstract] [Full Text] [Related]

  • 19. Determination of elastase-1 serum levels in post ERCP/EST pancreatic damage.
    Hardt PD, Fadgyas T, Kress O, Doppl WE, Weber HP, Bimler EA, Temme H, Klör HU.
    Z Gastroenterol; 1999 Aug 03; 37(8):701-5. PubMed ID: 10494604
    [Abstract] [Full Text] [Related]

  • 20. [The diagnostic significance of carbohydrate antigen 19-9 in pancreatic carcinomas].
    Chen YF.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Jun 03; 11(3):229-31. PubMed ID: 2529993
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.